— Know what they know.
Not Investment Advice
Also trades as: GBM.F (FSX) · $vol 0M · GBMB.F (FSX) · $vol 0M

INO Dividends

Inovio Pharmaceuticals, Inc.
1W: -11.9% 1M: -23.9% 3M: -14.4% YTD: -47.3% 1Y: -61.8% 3Y: -84.2% 5Y: -99.0%
$0.89
+0.02 (+2.32%)
 
Weekly Expected Move ±15.4%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 26 · $61.5M mcap · 82M float · 4.45% daily turnover · Short 31% of daily vol
Credit Risk of going bust: higher than 80% of companies Debt: 11.5% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the third-riskiest tenth, about 1 in 140 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.02 (down 98%), Inovio Pharmaceuticals, Inc. would be worth roughly what it owes.
Total debt $8.0M against a stock market value of $61.5M.
Distance to default 2.60 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $4.0M (short-term plus half of long-term), stock volatility 98.2%; Altman Z'' -130.58. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Dividend Overview

—%
Dividend Yield
$—
Annual Dividend
—%
Payout Ratio
—%
FCF Payout
0
Yr Increase Streak
—%
Buyback Yield
-78.36%
Total Return
—%
Chowder Number
Full Payment History (4 payments)
Ex-DateAmountAdj. AmountYieldFrequency
2017-09-28 $0.0057 $0.0690 36.45% Monthly
2017-08-29 $0.0057 $0.0690 28.99% Monthly
2017-07-27 $0.0057 $0.0690 20.87% Monthly
2017-06-28 $0.0057 $0.0690 6.99% Monthly
Stock Split History (3 splits)
DateRatioType
2024-01-25 1:12 stock-split
2014-06-06 1:4 stock-split
2004-09-13 1:4 stock-split

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms